CAS: 439087-18-0 - Elobixibat
Fórmula:C36H45N3O7S2
InChI:InChI=1S/C36H45N3O7S2/c1-4-6-18-36(19-7-5-2)24-39(27-16-12-9-13-17-27)28-20-30(47-3)29(21-31(28)48(44,45)25-36)46-23-32(40)38-34(26-14-10-8-11-15-26)35(43)37-22-33(41)42/h8-17,20-21,34H,4-7,18-19,22-25H2,1-3H3,(H,37,43)(H,38,40)(H,41,42)/t34-/m1/s1
Clave InChI:InChIKey=XFLQIRAKKLNXRQ-UUWRZZSWSA-N
SMILES:O=C(O)CNC(=O)C(NC(=O)COC=1C=C2C(=CC1SC)N(C=3C=CC=CC3)CC(CCCC)(CCCC)CS2(=O)=O)C=4C=CC=CC4
- Sinónimos:
- Glycine, (2R)-N-[[[3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- AZD 7806
- Glycine, (2R)-N-[2-[[3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- Elobixibat
- (2R)-N-[2-[[3,3-Dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycylglycine
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Elobixibat REF: 4Z-E-197001CAS: 439087-18-0 | - - - | A consultar | Jue 02 Ene 25 | |
Elobixibat REF: TR-E505200CAS: 439087-18-0 | - - - | 16.799,00 € | Lun 10 Feb 25 | |
Elobixibat REF: 3D-PSA08718CAS: 439087-18-0 | Min. 95% | 364,00 €~1.739,00 € | Mar 11 Feb 25 | |
Elobixibat REF: TM-T15209CAS: 439087-18-0 | 97.43% - 97.47% | 95,00 €~2.173,00 € | Mar 04 Mar 25 |
Ref: 4Z-E-197001
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Elobixibat
Producto controladoRef: TR-E505200
25mg | 16.799,00 € |
Elobixibat
Ref: 3D-PSA08718
1mg | 517,00 € | ||
2mg | 801,00 € | ||
5mg | 1.160,00 € | ||
10mg | 1.739,00 € | ||
500µg | 364,00 € |
Elobixibat
Ref: TM-T15209
1mg | 95,00 € | ||
5mg | 401,00 € | ||
10mg | 682,00 € | ||
25mg | 1.237,00 € | ||
50mg | 1.668,00 € | ||
100mg | 2.173,00 € |